Sustainable Manufacturing Cellino's focus on scalable biomanufacturing for personalized cell therapies positions them as a leading player in sustainable healthcare solutions, creating sales opportunities for eco-conscious customers and investors alike.
Strong Financial Backing With recent grants totaling $25 million and additional venture capital funding, Cellino Biotech demonstrates financial stability and growth potential, making them an attractive partner for collaboration and investment in the biotechnology sector.
Executive Expertise Expansion The strategic hiring of top talent like Ed Tekeian and Abhijit Kulkarni showcases Cellino's commitment to building a robust leadership team, presenting opportunities for networking, business partnerships, and attracting skilled professionals to drive innovation and growth.
Industry Recognition Cellino's substantial Series A financing led by notable investors such as Leaps by Bayer and Humboldt Fund underscores their industry credibility and innovation, paving the way for potential collaborations, joint ventures, and market expansion opportunities.
Competitive Market Position Compared to similar biotechnology companies like ClearCorrect and DDS Lab, Cellino's revenue range and innovative approach indicate competitive strength and differentiation, offering sales prospects for strategic alliances, acquisitions, and market positioning strategies.
487
$50M$100M
501$50M$100M
501$100M$1B
11K$1B
51$10M$50M
2.1K$100M$1B
91Cellino uses 8 technology products and services including MySQL, Shopify, Font Awesome, and more. Explore Cellino's tech stack below.
| Cellino Email Formats | Percentage |
| FLast@cellinobio.com | 50% |
| FLast@cellinobio.com | 50% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
Company Overview
Media & News
Funding & FinancialsCellino has raised a total of $25M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $25M.
Cellino's revenue is in the range of $10M$50M
Funding & FinancialsCellino has raised a total of $25M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $25M.
Cellino's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com